In 2023, China dominated the global share of the top 10% cited scientific publications in biotechnology with a significant lead at 48.9%, showing a growth of 11.43% year-on-year. The United States followed, trailing with 11.53% and experiencing a negative growth of 5.69%. Other notable contributors included India (4.66%), South Korea (3.41%), and the United Kingdom (2.82%), where India and Italy showed positive growth, whereas South Korea and the United Kingdom saw declines. Egypt, Malaysia, Saudi Arabia, and Kazakhstan exhibited the most substantial positive year-on-year growth, signaling burgeoning developments in these regions.
Looking ahead, China is expected to maintain its lead in top-cited biotechnology publications, driven by aggressive research investments and growing collaborations. Emerging players like Egypt, Malaysia, and Saudi Arabia are anticipated to continue gaining momentum with policy support and scientific advancements. Additionally, advancements in biotechnology innovation and cross-border collaborations could shape the global landscape, potentially redistributing the shares of top-cited publications among these rising markets.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Biotechnology Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 48.9 | 2023 | +11.01% | +11.43% | View data |
| 2 | 2 United States | 11.53 | 2023 | -5.43% | -5.69% | View data |
| 3 | 3 India | 4.66 | 2023 | +2.15% | +3.85% | View data |
| 4 | 4 South Korea | 3.41 | 2023 | +0.44% | -3.03% | View data |
| 5 | 5 United Kingdom | 2.82 | 2023 | +2.22% | -0.96% | View data |
| 6 | 6 Germany | 2.47 | 2023 | -5.54% | -5.76% | View data |
| 7 | 7 Italy | 2.26 | 2023 | +0.3% | +2.37% | View data |
| 8 | 8 Australia | 2 | 2023 | +3.83% | -1.5% | View data |
| 9 | 9 Spain | 1.71 | 2023 | +0.28% | -2.84% | View data |
| 10 | 10 Canada | 1.6 | 2023 | +1.98% | -0.69% | View data |
